Skip to main content
. 2023 Jan 1;24(1):762. doi: 10.3390/ijms24010762

Figure 2.

Figure 2

EVFEtOH and rutaecarpine inhibit 3CL protease activity. EVFEtOH (A) and rutaecarpin (B) both inhibited the activity of the enzyme in a dose-dependent manner. GC376 (100 µM) was used as a positive control. The data represent the mean ± SD percentage of inhibition to the control (with no drug treatment), and n = 4.